Abstract
Purpose
This study aimed to assess the incidence and difference of side effects among six courses of chemotherapy (C/T) in gynecological cancer patients.
Methods
The study period was from Sep. 2010 to Dec. 2011 at the Kaohsiung Veterans General Hospital in Taiwan. The treating protocols, courses, and drugs of C/T in patient were considered according to the different malignant cancers and clinical conditions. The patient data of age, marriage status, education, religion, and experiences of C/T were collected. The patients’ or their families’ reported side effects of C/T were recorded daily from the beginning of C/T to the 10th day after C/T in each cycle and every course of C/T.
Results
Total 89 patients enrolled into the study received total 450 courses of C/T. The mean age was 54.52 ± 11.02. Ovarian cancer was the most common malignant disease (64.0%). The most often combination of drugs used was Taxol and carboplatin (40.9%). Patients complained peripheral numbness of limbs, with the highest incidence of 58.6%. The side effects with incidence about 50% were decreased fatigue (55.0%) and hair loss (49.9%). Other side effects with different levels of incidence were also noticed, such as lack of appetite, changes in taste, and muscle ache. The incidences of peripheral limb numbness and hair loss were increased with following courses of C/T. The high incidence of fatigue did not show variation between different courses of C/T.
Conclusion
This study revealed the incidence of side effects and occurrence timing during C/T in patients with gynecological cancer. These data provide substantial information to patients and their families to understand the potential side effects of C/T courses, which might increase their compliance in receiving adjuvant C/T. Relieving the side effects in C/T would be important to improve their quality of daily life and treatment willingness.
Similar content being viewed by others
References
American Cancer Society (2015) Cancer facts and figures 2015. American Cancer Society, Atlanta
Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute (NCI). SEER cancer statistics factsheets: Cervix uteri cancer. Available at: http://seer.cancer.gov/statfacts/html/cervix.html. Accessed 29 Sept 2014
SEER, NCI. SEER cancer statistics factsheets: endometrial cancer. Available at: http://seer.cancer.gov/statfacts/html/corp.html. Accessed 29 Sept 2014
SEER, NCI. SEER cancer statistics factsheets: ovary cancer. Available at: http://seer.cancer.gov/statfacts/html/ovary.html. Accessed 29 Sept 2014
SEER, NCI. SEER cancer statistics factsheets: vulvar cancer. Available at: http://seer.cancer.gov/statfacts/html/vulva.html. Accessed 29 Sept 2014
Surveillance, Epidemiology, and End Results (SEER) (2013) Program of Ministry of Health and Welfare, Taiwan, 2013. Available at: http://www.mohw.gov.tw/cht/DOS/Statistic.aspx?f_list_no=312&fod_list_no=2747
Gloeckler Ries LA et al (2013) Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program. Oncologist 8(6):541–552
Sun CC, Ramirez PT, Bodurka DC (2007) Quality of life for patients with epithelial ovarian cancer. Nat Clin Pract Oncol 4(1):18–29
Seretny M et al (2014) Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. PAIN® 155(12):2461–2470
Mock V, Atkinson A, Barsevick A, Cella D, Cimprich B, Cleeland C et al (2000) NCCN practice guidelines for cancer-related fatigue. Oncology (Williston Park) 14:151–161
Cella D, Davis K, Breitbart W, Curt G (2001) Fatigue coalition. Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol 19:3385–3391
Ruffer JU, Flechtner H, Tralls P, Josting A, Sieber M, Lathan B et al (2003) Fatigue in long-term survivors of Hodgkin’s lymphoma; a report from the German Hodgkin Lymphoma Study Group (GHSG). Eur J Cancer 39:2179–2186
Vogelzang NJ, Breitbart W, Cella D, Curt GA, Groopman JE, Horning SJ et al (1997) Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol 34(3 Suppl 2):4–12
Lou Y, Yates P, McCarthy A, Wang H (2013) Fatigue self-management: a survey of Chinese cancer patients undergoing chemotherapy. J Clin Nurs 22(7–8):1053–1065
Shields K, Craig C, Baxter L, Renda L, Pipe J, Monk B, Chase D (2015) Cancer-related fatigue in gynecologic oncology patients undergoing chemotherapy. Gynecol Oncol 137(3):596
Wang SC, Borison HL (1950) The vomiting center: a critical experimental analysis. Arch Neurol Psychiatr 63:928–941
Miller AD, Wilson VJ (1983) “Vomiting center” reanalyzed: an electrical stimulation study. Brain res 270:154–158
Schmoll HJ, Aapro MS, Poli-Bigelli S et al (2006) Comparison of an aprepitant regimen with a multiple-day ondansetron regimen, both with dexamethasone, for antiemetic efficacy in high-dose cisplatin treatment. Ann Oncol 17:1000–1006
Pater JL, Lofters WS, Zee B et al (1997) The role of the 5-HT3 antagonists ondansetron and dolasetron in the control of delayed onset nausea and vomiting in patients receiving moderately emetogenic chemotherapy. Ann Oncol 8:181–185
Paul J, Hesketh N (2008) Chemotherapy-induced nausea and vomiting. Engl J Med 358:2482–2494
Kris MG et al (2006) American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. J Clin Oncol 24(18):2932–2947
Gralla RJ, Osoba D, Kris MG et al (1999) Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology. J Clin Oncol 17:2971–2994
Jordan K, Schmoll HJ, Aapro MS (2007) Comparative activity of antiemetic drugs. Crit Rev Oncol Hematol 61:162–175
Acknowledgements
The study was supported by grants from Kaohsiung Veterans General Hospital, Taiwan (VGHKS103-086), and Veterans General Hospital—National Sun Yat-Sen University (VGHNSU103-006), Taiwan.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval for this study was obtained from the KSVGH Institutional Review Board.
Funding
Hui-Chun Hsu received research funding (VGHKS103-086 and VGHNSU103-006) from Department of Nursing, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Hsu, HC., Tsai, SY., Wu, SL. et al. Longitudinal perceptions of the side effects of chemotherapy in patients with gynecological cancer. Support Care Cancer 25, 3457–3464 (2017). https://doi.org/10.1007/s00520-017-3768-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-017-3768-7